WTC–DiaSorin Day, 2026 - User's Meet & Update Training brings Global Expertise in Advanced CLIA Diagnostics to Nepal

Web Trading Concern Pvt. Ltd. (WTC), the Sole Authorized Exclusive Distributor of DiaSorin in Nepal, successfully organized WTC–DiaSorin Day 2026 on 3rd April 2026 at The Soaltee Kathmandu, bringing together Nepal's leading laboratory professionals, pathologists, microbiologists, clinicians, and users of the DiaSorin LIAISON® XL Fully Automated Chemiluminescence Immunoassay (CLIA) Analyzer.

The scientific gathering served as an important platform for knowledge exchange, showcasing the latest advancements in laboratory diagnostics while strengthening collaboration between healthcare professionals in Nepal and global experts from DiaSorin S.p.A., Italy—one of the world's leading manufacturers of innovative diagnostic solutions for immunodiagnostics and molecular diagnostics.

The event featured distinguished international speakers from DiaSorin APAC, including:

Mr. Joshua Glason – Vice President, APAC Dr. Jeff Chan (PhD) – Commercial Director, APAC Mr. Brad Vu – Senior Area Manager, APAC Export Ms. Kate Driver – Marketing Manager, APAC Ms. Andrea Goh – Product & Marketing Manager, APAC Export

Throughout the scientific sessions, participants were introduced to the latest developments within the DiaSorin LIAISON® platform, including newly available parameters, technological advancements, automation capabilities, and evolving diagnostic applications that continue to enhance laboratory efficiency, diagnostic accuracy, and clinical decision-making.

A major highlight of the program was the comprehensive discussion on QuantiFERON®-TB Gold Plus, an advanced blood-based assay for the detection of latent tuberculosis (TB) infection. With tuberculosis remaining a significant public health concern, experts shared valuable clinical insights into the importance of early latent TB diagnosis, updated testing recommendations, and the advantages of modern interferon-gamma release assay (IGRA) technology over conventional screening approaches.

The scientific agenda also covered significant updates in Gastrointestinal Diagnostics, emphasizing innovative biomarkers and laboratory approaches that support the diagnosis and management of gastrointestinal disorders. Sessions on Hepatitis and Retroviral Diagnostics highlighted advances in infectious disease testing, improved laboratory workflows, and enhanced clinical monitoring through automated immunoassay technologies.

Further presentations explored the expanding role of CLIA diagnostics in Endocrinology, with discussions focusing on hypertension, metabolic disorders, and tumor marker testing. Experts demonstrated how advanced immunodiagnostic assays contribute to earlier disease detection, better patient monitoring, and more informed clinical decisions.

Another key area of focus was Fertility and Women's Health Diagnostics, where speakers discussed the clinical importance of hormone testing and comprehensive TORCH panel screening for reproductive health, prenatal care, and maternal-fetal medicine. Participants gained valuable insights into the growing role of automated immunoassay systems in supporting fertility specialists and diagnostic laboratories.

The event encouraged active participation through engaging discussions, interactive question-and-answer sessions, and meaningful exchanges between international experts and Nepali laboratory professionals. Attendees had the opportunity to share practical experiences, discuss diagnostic challenges, and explore future opportunities for implementing advanced laboratory technologies within Nepal's healthcare system.

As the exclusive partner of DiaSorin in Nepal, Web Trading Concern Pvt. Ltd. reaffirmed its commitment to introducing globally recognized diagnostic innovations while supporting healthcare institutions through reliable product supply, technical expertise, application support, professional training, and responsive after-sales service.

WTC–DiaSorin Day 2026 reflected a shared vision of advancing laboratory medicine through innovation, education, and international collaboration. By connecting Nepal's healthcare community with global scientific expertise, the event further strengthened WTC's mission of empowering laboratories with cutting-edge diagnostic solutions that contribute to improved patient care across the country.

The successful completion of WTC–DiaSorin Day 2026 marked another significant milestone in WTC's ongoing partnership with DiaSorin S.p.A., reinforcing a long-term commitment to scientific excellence, continuous learning, and the future of diagnostic healthcare in Nepal.